vs

Side-by-side financial comparison of DUCOMMUN INC (DCO) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $215.8M, roughly 1.6× DUCOMMUN INC). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 3.4%, a 0.6% gap on every dollar of revenue. On growth, DUCOMMUN INC posted the faster year-over-year revenue change (9.4% vs 2.2%).

Ducommun Inc. is a global aerospace and defense manufacturing enterprise that provides complex structural components, electronic systems and professional engineering services. It mainly serves clients across the commercial aviation, military defense and space sectors, delivering high-reliability solutions for critical aerospace application scenarios.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

DCO vs GRDN — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.6× larger
GRDN
$336.6M
$215.8M
DCO
Growing faster (revenue YoY)
DCO
DCO
+7.2% gap
DCO
9.4%
2.2%
GRDN
Higher net margin
GRDN
GRDN
0.6% more per $
GRDN
4.0%
3.4%
DCO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DCO
DCO
GRDN
GRDN
Revenue
$215.8M
$336.6M
Net Profit
$7.4M
$13.5M
Gross Margin
27.7%
22.7%
Operating Margin
6.5%
5.3%
Net Margin
3.4%
4.0%
Revenue YoY
9.4%
2.2%
Net Profit YoY
9.9%
46.1%
EPS (diluted)
$0.52
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DCO
DCO
GRDN
GRDN
Q1 26
$336.6M
Q4 25
$215.8M
$397.6M
Q3 25
$212.6M
$377.4M
Q2 25
$202.3M
$344.3M
Q1 25
$194.1M
$329.3M
Q4 24
$197.3M
Q3 24
$201.4M
$314.4M
Q2 24
$197.0M
Net Profit
DCO
DCO
GRDN
GRDN
Q1 26
$13.5M
Q4 25
$7.4M
$20.9M
Q3 25
$-64.4M
$9.8M
Q2 25
$12.6M
$9.0M
Q1 25
$10.5M
$9.4M
Q4 24
$6.8M
Q3 24
$10.1M
$-122.0M
Q2 24
$7.7M
Gross Margin
DCO
DCO
GRDN
GRDN
Q1 26
22.7%
Q4 25
27.7%
21.5%
Q3 25
26.6%
19.8%
Q2 25
26.6%
19.8%
Q1 25
26.6%
19.5%
Q4 24
23.5%
Q3 24
26.2%
19.4%
Q2 24
26.0%
Operating Margin
DCO
DCO
GRDN
GRDN
Q1 26
5.3%
Q4 25
6.5%
7.7%
Q3 25
-37.7%
4.3%
Q2 25
8.5%
3.7%
Q1 25
8.5%
3.9%
Q4 24
5.3%
Q3 24
7.6%
-33.3%
Q2 24
7.1%
Net Margin
DCO
DCO
GRDN
GRDN
Q1 26
4.0%
Q4 25
3.4%
5.3%
Q3 25
-30.3%
2.6%
Q2 25
6.2%
2.6%
Q1 25
5.4%
2.9%
Q4 24
3.4%
Q3 24
5.0%
-38.8%
Q2 24
3.9%
EPS (diluted)
DCO
DCO
GRDN
GRDN
Q1 26
$0.21
Q4 25
$0.52
Q3 25
$-4.30
Q2 25
$0.82
Q1 25
$0.69
Q4 24
$0.45
Q3 24
$0.67
Q2 24
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DCO
DCO
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$45.3M
$64.9M
Total DebtLower is stronger
$298.8M
Stockholders' EquityBook value
$662.1M
$232.4M
Total Assets
$1.2B
$426.9M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DCO
DCO
GRDN
GRDN
Q1 26
$64.9M
Q4 25
$45.3M
$65.6M
Q3 25
$50.9M
$36.5M
Q2 25
$37.1M
$18.8M
Q1 25
$30.7M
$14.0M
Q4 24
$37.1M
Q3 24
$37.3M
$37.2M
Q2 24
$29.4M
Total Debt
DCO
DCO
GRDN
GRDN
Q1 26
Q4 25
$298.8M
$0
Q3 25
$215.0M
Q2 25
$218.1M
Q1 25
$229.9M
Q4 24
$229.8M
Q3 24
$246.0M
$34.3M
Q2 24
$250.9M
Stockholders' Equity
DCO
DCO
GRDN
GRDN
Q1 26
$232.4M
Q4 25
$662.1M
$217.9M
Q3 25
$649.0M
$195.5M
Q2 25
$707.8M
$179.7M
Q1 25
$693.0M
$163.2M
Q4 24
$682.5M
Q3 24
$665.6M
$133.9M
Q2 24
$655.9M
Total Assets
DCO
DCO
GRDN
GRDN
Q1 26
$426.9M
Q4 25
$1.2B
$412.7M
Q3 25
$1.2B
$390.0M
Q2 25
$1.1B
$356.3M
Q1 25
$1.1B
$334.0M
Q4 24
$1.1B
Q3 24
$1.1B
$348.0M
Q2 24
$1.1B
Debt / Equity
DCO
DCO
GRDN
GRDN
Q1 26
Q4 25
0.45×
0.00×
Q3 25
0.33×
Q2 25
0.31×
Q1 25
0.33×
Q4 24
0.34×
Q3 24
0.37×
0.26×
Q2 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DCO
DCO
GRDN
GRDN
Operating Cash FlowLast quarter
$-74.7M
$6.1M
Free Cash FlowOCF − Capex
$-78.8M
FCF MarginFCF / Revenue
-36.5%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
-10.03×
0.45×
TTM Free Cash FlowTrailing 4 quarters
$-48.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DCO
DCO
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$-74.7M
$34.6M
Q3 25
$18.1M
$28.2M
Q2 25
$22.4M
$19.9M
Q1 25
$771.0K
$17.6M
Q4 24
$18.4M
Q3 24
$13.9M
Q2 24
$3.5M
Free Cash Flow
DCO
DCO
GRDN
GRDN
Q1 26
Q4 25
$-78.8M
Q3 25
$16.0M
$24.2M
Q2 25
$18.1M
Q1 25
$-4.0M
Q4 24
$14.6M
Q3 24
$12.0M
Q2 24
$144.0K
FCF Margin
DCO
DCO
GRDN
GRDN
Q1 26
Q4 25
-36.5%
Q3 25
7.5%
6.4%
Q2 25
9.0%
Q1 25
-2.1%
Q4 24
7.4%
Q3 24
5.9%
Q2 24
0.1%
Capex Intensity
DCO
DCO
GRDN
GRDN
Q1 26
Q4 25
1.9%
Q3 25
1.0%
1.1%
Q2 25
2.1%
Q1 25
2.5%
Q4 24
2.0%
Q3 24
1.0%
Q2 24
1.7%
Cash Conversion
DCO
DCO
GRDN
GRDN
Q1 26
0.45×
Q4 25
-10.03×
1.65×
Q3 25
2.87×
Q2 25
1.79×
2.21×
Q1 25
0.07×
1.86×
Q4 24
2.72×
Q3 24
1.37×
Q2 24
0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DCO
DCO

Other$90.1M42%
Militaryand Space$60.0M28%
Electronic Systems Segment$31.3M15%
Commercial Aerospace$24.8M11%
Estimate At Completion Adjustment$6.6M3%
Industrial$3.0M1%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons